Top Contract Manufacturing organizations
Pharma Tech Outlook
Home »CMO » Top Contract Manufacturing organizations
Thermo Fisher Scientific [NYSE:TMO]: Pioneering The Path From Laboratory To Life-Saving Treatment
line

Top 10 Contract Manufacturing organizations - 2024

line

The pharmaceutical landscape in 2024 is marked by unprecedented innovation and adaptation. With the global pharmaceutical contract manufacturing market projected to reach $298.4 billion by 2030, the role of Contract Manufacturing Organizations (CMOs) has become more critical. The journey from drug discovery to market release, however, is fraught with regulatory hurdles, such as the current good manufacturing practice (cGMP) guidelines enforced by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and other global regulatory bodies.

Given the intricate nature of these complexities, biotechnology and pharmaceutical companies are increasingly relying on third-party vendors for development and manufacturing support. At the same time, the expiration of patents on blockbuster drugs is fueling the demand for high-quality generic manufacturing. Well-positioned to capitalize on this trend are CMOs with proven track records in compliance and quality assurance.

The landscape is also shaped by groundbreaking achievements and economic challenges from 2023. A notable milestone is the FDA’s historic approval of the first CRISPR-based gene therapy for sickle cell disease, which opens new horizons in genetic medicine. From a legislation standpoint, the Inflation Reduction Act’s impact on drug pricing negotiations aims to make medications more affordable without compromising quality and compliance standards.

In 2024 and beyond, the collaboration between CMOs and pharmaceutical companies will be essential in bringing novel therapies to patients worldwide. This edition of Pharma Tech Outlook delves into how the pharmaceutical landscape has a skyrocketing demand for reliable contract manufacturing support that can translate innovative ideas into viable, market-ready solutions.

It features thought leadership articles from Erik Lemay, Global Head of External Manufacturing at Servier, who discusses the ways to overcome the supply chain challenges in the medical industry, and Rachel Legmann, Senior Director of Technology, Gene Therapy at Repligen Corp, who elaborates on a unique platform approach to intensify virus-based therapeutics process manufacturing.

This publication highlights Dipharma, a global contract development and manufacturing organization (CDMO) and a leading manufacturer of active pharmaceutical ingredients (APIs) that handles hazardous chemical processes using state-of-the-art technologies. It also spotlights Altasciences, a one-stop shop for drug development, manufacturing and analytical services as well as fully integrated CRO services.

In this edition featuring the Top Contract Manufacturing Organizations 2024, we hope you find the right partner to meet your organization’s needs.

    Top Contract Manufacturing organizations

    Thermo Fisher Scientific [NYSE:TMO]
    Read full profile →
    Thermo Fisher Scientific’s Pharma Services pioneers transformative solutions in drug development. It bridges the gap from concept to cure by rewriting the drug development and marketing playbook. Thermo Fisher's strategy isn’t just about modifying existing methods but setting new benchmarks and shaping the future of healthcare. ... read full profile
    Abzena
    Read full profile →
    Abzena's combination of end-to-end services, flexibility, innovation, and global presence makes it a leader in the bioconjugate and complex biologics contract development and manufacturing organizations (CDMO) and Contract research organizations (CRO) space. ... read full profile
    Altasciences
    Read full profile →
    Altasciences’ CRO and CDMO services include preclinical safety testing, clinical research, bioanalysis and drug formulation and manufacturing, as well as a wide breadth of research support services, such as program and project management, regulatory guidance, medical writing, biostatics, clinical monitoring, and data management. ... read full profile
    Dipharma
    Read full profile →
    Dipharma is a global contract development and manufacturing organization (CDMO) and a leading manufacturer of active pharmaceutical ingredients (API) and intermediates, backed by its 75 years reliability and more than 50 years of pharmaceutical production and regulatory compliance experience. Through a comprehensive and regulated services suite, it supports customers along the entire lifecycle of a molecule, delivering a commitment to product excellence at the highest benchmarks. ... read full profile
    Formosa Laboratories
    Read full profile →
    Formosa Laboratories develops and manufactures APIs and Injectables with state-of-the-art technology under cGMP in compliance with the cGMP regulations. ... read full profile
    ABL
    ABL provides product development expertise, GMP manufacturing, and testing capabilities. As a biomedical research contractor, ABL advances diagnostics, vaccines, and therapeutics. Its CDMO division specializes in GMP cell banks and viral vectors, supporting gene therapies, viral vaccines, and protein vaccines. Services include bulk drug substance, fill/ finish, assay development, and bioanalytical testing
    AGC Biologics
    AGC Biologics provides industry expertise and customized services for cGMP manufacturing of protein-based therapeutics, mRNA, pDNA, viral vectors, and cell therapies. They utilize the CHEF1™ Expression System for efficient protein production. Their facilities help partners accelerate projects and manage product lifecycle spending.
    Andelyn Biosciences
    Andelyn Biosciences specializes in the development and manufacturing of gene therapies. They offer end-to-end solutions, including plasmid DNA production, viral vector manufacturing, and analytical testing. With state-of-the-art facilities, Andelyn supports clients from preclinical through commercial stages, ensuring high-quality, scalable, and compliant production of innovative gene therapy products.
    Avéma Pharma Solutions
    Avéma Pharma Solutions provides comprehensive contract development and manufacturing services for pharmaceuticals. They specialize in formulation development, analytical testing, and commercial manufacturing for oral solid doses, liquids, and semi-solids. With state-of-the-art facilities and a commitment to quality, Avéma partners with clients to bring high-quality pharmaceutical products to market efficiently.
    BioSpectra
    BioSpectra specializes in manufacturing high-purity chemicals and biopharmaceutical ingredients. They offer custom synthesis, purification, and analytical testing services. With a focus on quality and compliance, BioSpectra supports pharmaceutical, biotechnology, and life sciences industries in producing critical ingredients for various applications, ensuring reliability and consistency in their products.